NEW YORK (GenomeWeb) – DiaCarta today announced it raised $8 million in a Series A financing round.
Proceeds will go toward commercialization of its products and the expansion of its portfolio, it said, adding the financing came from BioVeda China Fund. In conjunction with BVCF's financing, Weixin Xu, a principal at the venture capital fund, will join DiaCarta's board.